Holly Ennis

862 total citations
27 papers, 403 citations indexed

About

Holly Ennis is a scholar working on Pathology and Forensic Medicine, Dermatology and General Health Professions. According to data from OpenAlex, Holly Ennis has authored 27 papers receiving a total of 403 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 6 papers in Dermatology and 6 papers in General Health Professions. Recurrent topics in Holly Ennis's work include Systemic Sclerosis and Related Diseases (11 papers), Dermatologic Treatments and Research (6 papers) and Acute Lymphoblastic Leukemia research (4 papers). Holly Ennis is often cited by papers focused on Systemic Sclerosis and Related Diseases (11 papers), Dermatologic Treatments and Research (6 papers) and Acute Lymphoblastic Leukemia research (4 papers). Holly Ennis collaborates with scholars based in United Kingdom, United States and Türkiye. Holly Ennis's co-authors include Ariane L. Herrick, Alan J. Silman, Eileen Baildam, Monica Bhushan, Michael Hughes, Andrea Murray, C.E.M. Griffiths, Helen L. Richards, Marina Anderson and Jack Wilkinson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Cochrane Database of Systematic Reviews.

In The Last Decade

Holly Ennis

24 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Holly Ennis United Kingdom 10 315 183 81 64 60 27 403
Anna Lis‐Święty Poland 13 222 0.7× 219 1.2× 29 0.4× 58 0.9× 55 0.9× 62 401
Carrie Richardson United States 11 195 0.6× 49 0.3× 86 1.1× 43 0.7× 149 2.5× 21 348
Laura Cometi Italy 12 130 0.4× 101 0.6× 29 0.4× 38 0.6× 106 1.8× 29 325
Egla Rabinovich United States 7 157 0.5× 81 0.4× 71 0.9× 79 1.2× 36 0.6× 10 497
Daniel Kietz United States 6 134 0.4× 67 0.4× 25 0.3× 29 0.5× 33 0.6× 12 276
Aurore Bergamasco United States 8 154 0.5× 46 0.3× 88 1.1× 27 0.4× 80 1.3× 16 322
N. Baudot France 11 128 0.4× 76 0.4× 23 0.3× 68 1.1× 51 0.8× 29 287
Florence Lachenal France 7 133 0.4× 43 0.2× 58 0.7× 41 0.6× 67 1.1× 21 363
Óscar Tellechea Portugal 10 114 0.4× 131 0.7× 32 0.4× 136 2.1× 80 1.3× 30 358
K V Ratnam Singapore 11 206 0.7× 118 0.6× 23 0.3× 24 0.4× 46 0.8× 20 368

Countries citing papers authored by Holly Ennis

Since Specialization
Citations

This map shows the geographic impact of Holly Ennis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holly Ennis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holly Ennis more than expected).

Fields of papers citing papers by Holly Ennis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holly Ennis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holly Ennis. The network helps show where Holly Ennis may publish in the future.

Co-authorship network of co-authors of Holly Ennis

This figure shows the co-authorship network connecting the top 25 collaborators of Holly Ennis. A scholar is included among the top collaborators of Holly Ennis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holly Ennis. Holly Ennis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Weir, Christopher J., Susan Hinder, Holly Ennis, et al.. (2024). A complex ePrescribing antimicrobial stewardship-based (ePAMS+) intervention for hospitals: mixed-methods feasibility trial results. BMC Medical Informatics and Decision Making. 24(1). 301–301.
3.
Hanna, Catherine, et al.. (2024). Variation in colorectal cancer treatment and outcomes in Scotland: real world evidence from national linked administrative health data. International Journal for Population Data Science. 9(1).
4.
Weir, Christopher J., Holly Ennis, Robin Williams, et al.. (2023). A complex ePrescribing-based Anti-Microbial Stewardship (ePAMS+) intervention for hospitals combining technological and behavioural components: protocol for a feasibility trial. Pilot and Feasibility Studies. 9(1). 18–18. 2 indexed citations
5.
Cresswell, Kathrin, Susan Hinder, Aziz Sheikh, et al.. (2023). ePrescribing-Based Antimicrobial Stewardship Practices in an English National Health Service Hospital: Qualitative Interview Study Among Medical Prescribers and Pharmacists. JMIR Formative Research. 7. e37863–e37863. 4 indexed citations
6.
Hanna, Catherine, Peter Hall, Holly Ennis, et al.. (2022). Cancer Trial Impact: Understanding Implementation of the Short Course Oncology Treatment (SCOT) Trial Findings in colorectal cancer at a National Level. Clinical Oncology. 34(9). 554–560. 2 indexed citations
7.
Hanna, Catherine, Holly Ennis, Robert J. Jones, et al.. (2021). Creation of the first national linked colorectal cancer dataset in Scotland: prospects for future research and a reflection on lessons learned. International Journal for Population Data Science. 6(1). 1654–1654. 6 indexed citations
8.
Murray, Andrea, Tonia Moore, Holly Ennis, et al.. (2017). Pilot study assessing pathophysiology and healing of digital ulcers in patients with systemic sclerosis using laser Doppler imaging and thermography.. Clinical and Experimental Rheumatology. 34 Suppl 100(5). 100–105. 3 indexed citations
9.
Arnott, Ian, Craig Mowat, Holly Ennis, et al.. (2016). OP026. The TOPPIC Trial: a randomised, double-blind parallel-group trial of mercaptopurine versus placebo to prevent recurrence of Crohn’s disease following surgical resection in 240 patients. Journal of Crohn s and Colitis. 10(suppl 1). S21–S22. 2 indexed citations
10.
11.
Ennis, Holly, Michael Hughes, Marina Anderson, Jack Wilkinson, & Ariane L. Herrick. (2016). Calcium channel blockers for primary Raynaud's phenomenon. Cochrane Database of Systematic Reviews. 2016(7). CD002069–CD002069. 44 indexed citations
12.
13.
Hughes, Michael, Tonia Moore, Neil O’Leary, et al.. (2015). A study comparing videocapillaroscopy and dermoscopy in the assessment of nailfold capillaries in patients with systemic sclerosis–spectrum disorders. Lara D. Veeken. 54(8). 1435–1442. 53 indexed citations
14.
Ennis, Holly, Andy Vail, A. E. Taylor, et al.. (2013). A prospective study of systemic sclerosis-related digital ulcers: prevalence, location, and functional impact. Scandinavian Journal of Rheumatology. 42(6). 483–486. 39 indexed citations
15.
Murray, Andrea, Tonia Moore, Helen L. Richards, et al.. (2012). Pilot study of intense pulsed light for the treatment of systemic sclerosis-related telangiectases. British Journal of Dermatology. 167(3). 563–569. 11 indexed citations
16.
Herrick, Ariane L., Holly Ennis, M. Bhushan, Alan J. Silman, & Eileen Baildam. (2011). Clinical features of childhood localized scleroderma in an incidence cohort. Lara D. Veeken. 50(10). 1865–1868. 19 indexed citations
17.
Herrick, Ariane L., Holly Ennis, Monica Bhushan, Alan J. Silman, & Eileen Baildam. (2010). Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland. Arthritis Care & Research. 62(2). 213–218. 103 indexed citations
18.
Baildam, Eileen, Holly Ennis, Helen Foster, et al.. (2010). Influence of Childhood Scleroderma on Physical Function and Quality of Life. The Journal of Rheumatology. 38(1). 167–173. 30 indexed citations
19.
Ennis, Holly, et al.. (2009). Incidence of childhood scleroderma in the UK and Ireland..
20.
Herrick, Ariane L., Mark Lunt, Holly Ennis, et al.. (2009). Observational Study of Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis. The Journal of Rheumatology. 37(1). 116–124. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Lis‐Święty Breakdown of academic impact, for papers by Carrie Richardson Breakdown of academic impact, for papers by Laura Cometi Breakdown of academic impact, for papers by Egla Rabinovich Breakdown of academic impact, for papers by Daniel Kietz Breakdown of academic impact, for papers by Aurore Bergamasco Breakdown of academic impact, for papers by N. Baudot Breakdown of academic impact, for papers by Florence Lachenal Breakdown of academic impact, for papers by Óscar Tellechea Breakdown of academic impact, for papers by K V Ratnam
Rankless by CCL
2026